News - Brightlands Venture Partners

ReSolved Technologies: “Confidence in the product and the partnership!”

October 06, 2025

AVL MOTION: “Aiming to solve the major challenge: labour shortages!”

September 02, 2025

Matisse Pharmaceuticals & EpiDisease receive EU funding for their eHISTOCURE project

June 26, 2025

Hy2Care® secures €4.5 million in funding to prepare for U.S. clinical trial and commercial expansion

May 14, 2025

Hy2Care® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant

April 17, 2025

Grassa Raises EUR 3.6 Million; Grass Protein Consumption by Humans Draws Closer

March 19, 2025

Vivalyx Backed by EIC Accelerator with up to €8.5M to Advance Organ Revitalization Technology

February 20, 2025

Pierpaolo Padula joins Health Team BVP

January 20, 2025

Matisse Pharmaceuticals receives BfArM approval to study a prolonged infusion of M6229

October 24, 2024

Bio-Engineering scale-up Qorium unveils cultivated leather breakthrough, marking major progress toward commercialization

October 23, 2024

Matisse Pharmaceuticals appoints Prof. Carolyn Calfee to the Scientific Board

October 22, 2024

PL BioScience closes € 7.8 million Series A Financing

August 08, 2024

More information

If you have any questions or want to know more about us
Contact us